First Time Loading...

Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399

Watchlist Manager
Jiangsu Bioperfectus Technologies Co Ltd Logo
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Watchlist
Price: 73.07 CNY 0.08% Market Closed
Updated: May 16, 2024

Jiangsu Bioperfectus Technologies Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Bioperfectus Technologies Co Ltd
Cost of Revenue Peer Comparison

Comparables:
1066
S
600529
603658
300888
300832

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Cost of Revenue
-¥253.9m
CAGR 3-Years
13%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Cost of Revenue
-¥6.6B
CAGR 3-Years
-9%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Cost of Revenue
-¥3.6B
CAGR 3-Years
-13%
CAGR 5-Years
-16%
CAGR 10-Years
-12%
Autobio Diagnostics Co Ltd
SSE:603658
Cost of Revenue
-¥1.6B
CAGR 3-Years
-6%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Cost of Revenue
-¥4.4B
CAGR 3-Years
6%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Cost of Revenue
-¥1.1B
CAGR 3-Years
-28%
CAGR 5-Years
-32%
CAGR 10-Years
N/A

See Also

What is Jiangsu Bioperfectus Technologies Co Ltd's Cost of Revenue?
Cost of Revenue
-253.9m CNY

Based on the financial report for Dec 31, 2023, Jiangsu Bioperfectus Technologies Co Ltd's Cost of Revenue amounts to -253.9m CNY.

What is Jiangsu Bioperfectus Technologies Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-43%

Over the last year, the Cost of Revenue growth was 89%. The average annual Cost of Revenue growth rates for Jiangsu Bioperfectus Technologies Co Ltd have been 13% over the past three years , -43% over the past five years .